Hidden superbug in UTIs under the microscope
NCT ID NCT07204769
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a little-known bacteria called Providencia that can cause urinary tract infections (UTIs). Researchers will collect samples from 241 patients to identify the germ, test which antibiotics work against it, and look for genes that make it resistant to drugs. The goal is to learn more about this emerging pathogen so doctors can better treat these infections in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors choose better antibiotics for hard-to-treat Providencia UTIs.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly cure or prevent infections, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 241 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with UTI diagnosed through clinical examination and urine analysis.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients with UTI diagnosed through clinical examination and urine analysis. Informed consent will be obtained from each patient before Participation in the study. Exclusion Criteria: 1. Patients currently on antibiotics. 2. Patients with any anatomical abnormalities in the urinary tract C) Patients having UTI by gram +ve organisms.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Urinary tract infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Assiut University
Asyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What lurks in urine? a biobank aims to decode Catheter-Related infections
- Can an ancient herbal formula beat antibiotics for urinary infections?
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Home hospital care for infections: when does it fail?
- Simple urine test could revolutionize schistosomiasis detection
- Stop the pills when symptoms vanish? landmark trial for Kids' infections